|
Schlusskurs
Mexican S.E.
25.08.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 2’520.00 MXN | +1.82% |
|
+5.52% | +13.40% |
| 25.08. | Morning Meeting: Viel Lärm um nichts? |  |
| 25.08. | Lakefront Biotherapeutics, Gilead sichern sich in den USA weitere Orphan-Drug-Zulassung für Medikament gegen Hauterkrankung | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.59% | -7.10% | -0.55% | +11.71% | +10.68% | +61.60% | +114.83% | +355.15% | +1’420.21% | 1’100 Mrd. | |
| -1.15% | -1.25% | +2.51% | +17.30% | +30.47% | +52.98% | +62.41% | +55.80% | +126.81% | 658 Mrd. | |
| -1.09% | -1.15% | +1.36% | +23.36% | +15.06% | +26.18% | +79.22% | +118.36% | +306.90% | 470 Mrd. | |
| -1.47% | +0.24% | +3.72% | +11.20% | +12.22% | +42.09% | +42.09% | +0.70% | +52.89% | 372 Mrd. | |
| -0.90% | +0.05% | +0.22% | +7.38% | +16.04% | +25.57% | +41.75% | +50.97% | +64.32% | 304 Mrd. | |
| -1.94% | +1.53% | -5.07% | -12.36% | -11.28% | +3.05% | +13.24% | +42.59% | +146.90% | 264 Mrd. | |
| -0.43% | -0.46% | +17.10% | +31.08% | +34.53% | +52.06% | +71.75% | +98.83% | +156.06% | 239 Mrd. | |
| -0.93% | +1.84% | -4.88% | +6.11% | -6.24% | -13.11% | -52.28% | -7.25% | +96.24% | 213 Mrd. | |
| -0.46% | +0.33% | +14.52% | +10.74% | +20.65% | +29.05% | +92.67% | +107.32% | +85.65% | 184 Mrd. | |
| -0.95% | +0.21% | +15.32% | +9.48% | +13.65% | +13.56% | -22.21% | -40.27% | -18.72% | 163 Mrd. | |
| -1.01% | -0.86% | +14.65% | +25.55% | +20.72% | +41.35% | +56.34% | +176.06% | +463.69% | 140 Mrd. | |
| -0.52% | -0.06% | +8.83% | +16.44% | +25.27% | +43.13% | +8.84% | +0.87% | +14.97% | 139 Mrd. | |
| -0.57% | -0.34% | +2.97% | +2.58% | -5.36% | -9.26% | -20.69% | -11.49% | +12.89% | 110 Mrd. | |
| -0.31% | -0.86% | -3.14% | -1.32% | +4.11% | +29.26% | +35.89% | +2.77% | -7.88% | 104 Mrd. | |
| -1.49% | +1.00% | +1.55% | -8.33% | -15.64% | +15.69% | +57.58% | +62.29% | +544.88% | 71.79 Mrd. | |
| -1.30% | +0.35% | +0.35% | +14.41% | +19.73% | +31.51% | +29.45% | +57.95% | +28.96% | 58.27 Mrd. | |
| -0.30% | +0.20% | +6.62% | +29.85% | +32.69% | +71.77% | -1.88% | +3.74% | -49.37% | 56.48 Mrd. | |
| -0.58% | -11.23% | -13.02% | -5.95% | -21.96% | -29.84% | +14.17% | -1.94% | +183.98% | 45.53 Mrd. | |
| -0.47% | +1.20% | +23.08% | +9.56% | +21.50% | +108.93% | +290.93% | +307.74% | -26.44% | 44.4 Mrd. | |
| Durchschnitt | -1.01% | +0.02% | +4.53% | +10.46% | +11.41% | +31.35% | +48.11% | +72.64% | +189.63% | 249.22 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -1.61% | -1.18% | +3.01% | +12.40% | +14.01% | +38.15% | +60.35% | +124.73% | +433.06% |
- Börse
- Aktien
- 885823 Aktie
- 885823 Aktie
- Sektor Gilead Sciences, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
